Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Fruman

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Oncotarget|October 14, 2015
MCL-1-independent mechanisms of synergy between dual PI3K/mTOR and BCL-2 inhibition in diffuse large B cell lymphomaJ Scott Lee, Sarah S Tang, Veronica Ortiz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
Class IA phosphoinositide 3-kinase modulates basal lymphocyte motility in the lymph nodeMelanie P Matheu, Jonathan A Deane, Ian Parker, et al.
Autoimmunity|October 9, 2009
The p85beta regulatory subunit of phosphoinositide 3-kinase has unique and redundant functions in B cellsJean S Oak, Jing Chen, Raechel Q Peralta, et al.
Cell|August 13, 2017
The PI3K Pathway in Human DiseaseDavid A Fruman, Honyin Chiu, Benjamin D Hopkins, et al.
Journal of Leukocyte Biology|October 6, 2005
S6 kinase 2 potentiates interleukin-3-driven cell proliferationRebecca Cruz, Lee Hedden, Derek Boyer, et al.
Plos One|March 4, 2014
Resistance to mTOR kinase inhibitors in lymphoma cells lacking 4EBP1Sharmila Mallya, Briana A Fitch, J Scott Lee, et al.
Plos One|June 11, 2014
Effects of novel isoform-selective phosphoinositide 3-kinase inhibitors on natural killer cell functionSung Su Yea, Lomon So, Sharmila Mallya, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2004
Enhanced T cell proliferation in mice lacking the p85beta subunit of phosphoinositide 3-kinaseJonathan A Deane, Matthew J Trifilo, Claudine M Yballe, et al.
Molecular Endocrinology (Baltimore, Md.)|March 26, 2011
B-1 cell lymphoma in mice lacking the steroid and xenobiotic receptor, SXRStephanie C Casey, Edward L Nelson, Gina M Turco, et al.
European Journal of Immunology|September 24, 2004
Frontline: The p85alpha isoform of phosphoinositide 3-kinase is essential for a subset of B cell receptor-initiated signaling responsesKristen L Hess, Amber C Donahue, Kwan L Ng, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Oncotarget|October 14, 2015
MCL-1-independent mechanisms of synergy between dual PI3K/mTOR and BCL-2 inhibition in diffuse large B cell lymphomaJ Scott Lee, Sarah S Tang, Veronica Ortiz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
Class IA phosphoinositide 3-kinase modulates basal lymphocyte motility in the lymph nodeMelanie P Matheu, Jonathan A Deane, Ian Parker, et al.
Autoimmunity|October 9, 2009
The p85beta regulatory subunit of phosphoinositide 3-kinase has unique and redundant functions in B cellsJean S Oak, Jing Chen, Raechel Q Peralta, et al.
Cell|August 13, 2017
The PI3K Pathway in Human DiseaseDavid A Fruman, Honyin Chiu, Benjamin D Hopkins, et al.
Journal of Leukocyte Biology|October 6, 2005
S6 kinase 2 potentiates interleukin-3-driven cell proliferationRebecca Cruz, Lee Hedden, Derek Boyer, et al.
Plos One|March 4, 2014
Resistance to mTOR kinase inhibitors in lymphoma cells lacking 4EBP1Sharmila Mallya, Briana A Fitch, J Scott Lee, et al.
Plos One|June 11, 2014
Effects of novel isoform-selective phosphoinositide 3-kinase inhibitors on natural killer cell functionSung Su Yea, Lomon So, Sharmila Mallya, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2004
Enhanced T cell proliferation in mice lacking the p85beta subunit of phosphoinositide 3-kinaseJonathan A Deane, Matthew J Trifilo, Claudine M Yballe, et al.
Molecular Endocrinology (Baltimore, Md.)|March 26, 2011
B-1 cell lymphoma in mice lacking the steroid and xenobiotic receptor, SXRStephanie C Casey, Edward L Nelson, Gina M Turco, et al.
European Journal of Immunology|September 24, 2004
Frontline: The p85alpha isoform of phosphoinositide 3-kinase is essential for a subset of B cell receptor-initiated signaling responsesKristen L Hess, Amber C Donahue, Kwan L Ng, et al.
Pageof 11